Back
Atara Biotherapeutics Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
48
ATRA
Atara Biotherapeutics
Last Price:
11.99
Seasonality Move:
37.22%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- The current trend is moderately bullish and ATRA is experiencing slight selling pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.75 | Buy |
| 20-day SMA: | 10.28 | Buy |
| 50-day SMA: | 9 | Buy |
| 200-day SMA: | 12.83 | Sell |
| 8-day EMA: | 11.89 | Buy |
| 20-day EMA: | 10.7 | Buy |
| 50-day EMA: | 9.64 | Buy |
| 200-day EMA: | 14.91 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.08 | Buy |
| Relative Strength Index (14 RSI): | 59.39 | Buy |
| Chaikin Money Flow: | -31367 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.45 - 11.57) | Buy |
| Bollinger Bands (100): | (7.32 - 10.36) | Buy |
Atara Biotherapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 12.00 while ATRA 8-day simple moving average is 11.75, which is a Buy signal.
- The stock price of ATRA is 12.00 while Atara Biotherapeutics 20-day SMA is 10.28, which makes it a Buy.
- Atara Biotherapeutics 50-day simple moving average is 9.00 while ATRA share price is 12.00, making it a Buy technically.
- ATRA stock price is 12.00 and Atara Biotherapeutics 200-day simple moving average is 12.83, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
48
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a Sell
The current Atara Biotherapeutics [ATRA] share price is $12.00. The Score for ATRA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
68.09M
Price in USD:
12.00
Share Volume:
107.87K
Atara Biotherapeutics 52-Week Range
52-Week High:
39.50
52-Week Low:
6.50
Sell
48
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?
The Atara Biotherapeutics stock price is 12.00 USD today. -
Will ATRA stock go up or go down?
Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Atara Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 12.00 while ATRA 8-day exponential moving average is 11.89, which is a Buy signal.
- The stock price of ATRA is 12.00 while Atara Biotherapeutics 20-day EMA is 10.70, which makes it a Buy.
- Atara Biotherapeutics 50-day exponential moving average is 9.64 while ATRA share price is 12.00, making it a Buy technically.
- ATRA stock price is 12.00 and Atara Biotherapeutics 200-day simple moving average is 14.91, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $13.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $56.86 per share, and a decrease next year of $3.35 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
- ATRA Moving Average Covergence Divergence (MACD) indicator is 1.08, suggesting Atara Biotherapeutics is a Buy
- Atara Biotherapeutics Relative Strength Index (RSI) is 59.39, which suggest Atara Biotherapeutics is overbought
- The Bollinger Bands (25) for Atara Biotherapeutics is (8.45 - 11.57), which suggest Atara Biotherapeutics is a Buy
- The Bollinger Bands (100) for Atara Biotherapeutics is (7.32 - 10.36), which suggest Atara Biotherapeutics is a Buy
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.